Literature DB >> 18777135

Expression profile of microRNAs in c-Myc induced mouse mammary tumors.

Yuan Sun1, Jack Wu, Si-hung Wu, Archana Thakur, Aliccia Bollig, Yong Huang, D Joshua Liao.   

Abstract

c-Myc is a transcription factor overexpression of which induces mammary cancer in transgenic mice. To explore whether certain microRNAs (mirRNA) mediate c-Myc induced mammary carcinogenesis, we studied mirRNA expression profile in mammary tumors developed from MMTV-c-myc transgenic mice, and found 50 and 59 mirRNAs showing increased and decreased expression, respectively, compared with lactating mammary glands of wild type mice. Twenty-four of these mirRNAs could be grouped into eight clusters because they had the same chromosomal localizations and might be processed from the same primary RNA transcripts. The increased expression of mir-20a, mir-20b, and mir-9 as well as decreased expression of mir-222 were verified by RT-PCR, real-time RT-PCR, and cDNA sequencing. Moreover, we fortuitously identified a novel non-coding RNA, the level of which was decreased in proliferating mammary glands of MMTV-c-myc mice was further decreased to undetectable level in the mammary tumors. Sequencing of this novel RNA revealed that it was transcribed from a region of mouse chromosome 19 that harbored the metastasis associated lung adenocarcinoma transcript-1 (Malat-1), a non-protein-coding gene. These results suggest that certain mirRNAs and the chromosome 19 derived non-coding RNAs may mediate c-myc induced mammary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777135      PMCID: PMC3882315          DOI: 10.1007/s10549-008-0171-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  66 in total

1.  Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour.

Authors:  Md Golam Sabbir; Anup Roy; Syamsundar Mandal; Aniruddha Dam; Susanta Roychoudhury; Chinmay Kumar Panda
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Long, abundantly expressed non-coding transcripts are altered in cancer.

Authors:  Damon S Perez; Tiffany R Hoage; Jay R Pritchett; Allison L Ducharme-Smith; Meredith L Halling; Sree C Ganapathiraju; Paul S Streng; David I Smith
Journal:  Hum Mol Genet       Date:  2007-11-15       Impact factor: 6.150

3.  An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers.

Authors:  T Timmer; P Terpstra; A van den Berg; P M Veldhuis; A Ter Elst; A Y van der Veen; K Kok; S L Naylor; C H Buys
Journal:  Genomics       Date:  1999-09-01       Impact factor: 5.736

4.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  MicroRNA genes are frequently located near mouse cancer susceptibility loci.

Authors:  Cinzia Sevignani; George A Calin; Stephanie C Nnadi; Masayoshi Shimizu; Ramana V Davuluri; Terry Hyslop; Peter Demant; Carlo M Croce; Linda D Siracusa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

7.  Loss of heterozygosity on the X chromosome in human breast cancer.

Authors:  M L Loupart; S Adams; J A Armour; R Walker; W Brammar; J Varley
Journal:  Genes Chromosomes Cancer       Date:  1995-08       Impact factor: 5.006

8.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression.

Authors:  Olga Kovalchuk; Volodymyr P Tryndyak; Beverly Montgomery; Alex Boyko; Kristy Kutanzi; Franz Zemp; Alan R Warbritton; John R Latendresse; Igor Kovalchuk; Frederick A Beland; Igor P Pogribny
Journal:  Cell Cycle       Date:  2007-06-06       Impact factor: 4.534

10.  Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.

Authors:  Marjan M Weiss; Ernst J Kuipers; Cindy Postma; Antoine M Snijders; Daniel Pinkel; Stefan G M Meuwissen; Donna Albertson; Gerrit A Meijer
Journal:  Cell Oncol       Date:  2004       Impact factor: 6.730

View more
  41 in total

1.  Myc-modulated miR-9 makes more metastases.

Authors:  Yeesim Khew-Goodall; Gregory J Goodall
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

2.  miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.

Authors:  Haifeng Wang; Wei Zhang; Yigang Zuo; Mingxia Ding; Changxing Ke; Ruping Yan; Hui Zhan; Jingyu Liu; Jiansong Wang
Journal:  Tumour Biol       Date:  2015-07-07

3.  Identification of differential expressed transcripts in cervical cancer of Mexican patients.

Authors:  Leticia Santos; Ma Fabiola León-Galván; Erika Nahomy Marino-Marmolejo; Ana Paulina Barba de la Rosa; Antonio De León Rodríguez; Roberto González-Amaro; Ramón Gerardo Guevara-González
Journal:  Tumour Biol       Date:  2011-01-13

4.  FARNA: knowledgebase of inferred functions of non-coding RNA transcripts.

Authors:  Tanvir Alam; Mahmut Uludag; Magbubah Essack; Adil Salhi; Haitham Ashoor; John B Hanks; Craig Kapfer; Katsuhiko Mineta; Takashi Gojobori; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2017-03-17       Impact factor: 16.971

5.  Effect of SMYD3 on the microRNA expression profile of MCF-7 breast cancer cells.

Authors:  Dongju Chen; Lei Liu; Xuegang Luo; Ai Mu; Lihua Yan; Xiaoying Chen; Lei Wang; Nan Wang; Hongpeng He; Hao Zhou; Tongcun Zhang
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

6.  Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.

Authors:  German G Gomez; Stefano Volinia; Carlo M Croce; Ciro Zanca; Ming Li; Ryan Emnett; David H Gutmann; Cameron W Brennan; Frank B Furnari; Webster K Cavenee
Journal:  Cancer Res       Date:  2014-01-16       Impact factor: 12.701

7.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Authors:  Li Ma; Jennifer Young; Harsha Prabhala; Elizabeth Pan; Pieter Mestdagh; Daniel Muth; Julie Teruya-Feldstein; Ferenc Reinhardt; Tamer T Onder; Scott Valastyan; Frank Westermann; Frank Speleman; Jo Vandesompele; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

8.  Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.

Authors:  Anna Onnis; Giulia De Falco; Giuseppina Antonicelli; Monica Onorati; Cristiana Bellan; Omar Sherman; Shaheen Sayed; Lorenzo Leoncini
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

Review 9.  MicroRNAs in human cancer.

Authors:  Thalia A Farazi; Jessica I Hoell; Pavel Morozov; Thomas Tuschl
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

10.  Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration.

Authors:  Zhang Lei; Bo Li; Zhuoshun Yang; Haoshu Fang; Gui-Mei Zhang; Zuo-Hua Feng; Bo Huang
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.